Bone Abstracts

Background: Bisphosphonates (BP) are widely used in osteoporosis treatment. By inhibiting the mevalonate pathway, bisphosphonates may affect cell function and survival, including the viability of tumor cells. Recently, a protective effect of bisphosphonates on breast cancer risk has been suggested by several studies, which were unable to exclude the possibility of a confounder effect due to low cumulative exposure to estrogen in osteoporotic women vs controls.<p class="abs...